| NDC Code | 0703-5043-03 |
|---|
| Package Description | 10 VIAL, SINGLE-DOSE in 1 TRAY (0703-5043-03) > 5 mL in 1 VIAL, SINGLE-DOSE (0703-5043-01) |
|---|
| Product NDC | 0703-5043 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Doxorubicin Hydrochloride |
|---|
| Non-Proprietary Name | Doxorubicin Hydrochloride |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 19950901 |
|---|
| End Marketing Date | 20190331 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA064140 |
|---|
| Manufacturer | Teva Parenteral Medicines, Inc. |
|---|
| Substance Name | DOXORUBICIN HYDROCHLORIDE |
|---|
| Strength | 2 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA] |
|---|